RoomsShowsRankingsEarnings CalendarShop
Cancel
DOW0.00%
S&P 5000.00%
NASDAQ0.00%
Trending now
drsnipes2/17/21, 02:16 PM
$ALT clinicaltrials.gov/ct2/show... Phase 1 study expected to be completed by Feb 2022 Remember it has 3 phases before approval. No warp speed here.

Safety and Immunogenicity of AdCOVID in Healthy Adults (COVID-19 Vaccine Study) - Full Text View - ClinicalTrials.gov

via: Clinicaltrials
1
2
2 Likes